Get started
Author

Emily R. Ko

Observed names: Emily Ko, Emily R Ko, Emily Ray Ko, Ko, Emily R, Ko, Emily R.
Observed institutions: Parkland Health & Hospital System, The University of Texas at San Antonio Health Science Center, Duke University, Baylor College of Medicine, National and Kapodistrian University of Athens, Duke Regional Hospital, Baylor University Medical Center, Duke Medical Center, Stanford Medicine, Association Clinique et Thérapeutique Infantile du Val de Marne, South Texas Veterans Health Care System, Duke University Health System, Atlanta VA Health Care System, VA Nebraska Western Iowa Health Care System, Evangelismos Hospital, University of Nebraska Medical Center, The University of Texas Southwestern Medical Center, Stanford University
ORCID: 0000-0003-0542-3750
Observed ORCID: 0000-0003-0542-3750
OpenAlex ID: A5018629539
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19
2020 · Andre C. Kalil, Thomas F. Patterson, et al. · New England Journal of Medicine · 1,836
Host gene expression classifiers diagnose acute respiratory illness etiology
2016 · Ephraim L. Tsalik, Ricardo Henao, et al. · Science Translational Medicine · 254
PDF
Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial
2022 · Self, Wesley H, Sandkovsky, Uriel, et al. · Research at the University of Copenhagen (University of Copenhagen) · 188
Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial
2022 · Cameron R Wolfe, Kay M Tomashek, et al. · The Lancet Respiratory Medicine · 123
An atlas connecting shared genetic architecture of human diseases and molecular phenotypes provides insight into COVID-19 susceptibility
2021 · Liuyang Wang, Thomas J. Balmat, et al. · Genome Medicine · 85
PDF
Abatacept, Cenicriviroc, or Infliximab for Treatment of Adults Hospitalized With COVID-19 Pneumonia
2023 · Jane A. O’Halloran, Emily R. Ko, et al. · JAMA · 70
PDF
The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19
2022 · ACTIV-3/TICO Study Group, Angela J. Rogers, et al. · Annals of Internal Medicine · 60
PDF
Validation of a host response test to distinguish bacterial and viral respiratory infection
2019 · Emily C. Lydon, Ricardo Henao, et al. · EBioMedicine · 58
PDF
Discriminating Bacterial and Viral Infection Using a Rapid Host Gene Expression Test*
2021 · Ephraim L. Tsalik, Ricardo Henao, et al. · Critical Care Medicine · 50
The Host Response to Viral Infections Reveals Common and Virus-Specific Signatures in the Peripheral Blood
2021 · Ephraim L. Tsalik, Cassandra Fiorino, et al. · Frontiers in Immunology · 44
Mucosal-associated invariant T cell responses differ by sex in COVID-19
2021 · Chen Yu, Sejiro Littleton, et al. · Med · 42
PDF
Differential chromatin accessibility in peripheral blood mononuclear cells underlies COVID-19 disease severity prior to seroconversion
2022 · Nicholas S. Giroux, Shengli Ding, et al. · Scientific Reports · 39
PDF
Systematic comparison of published host gene expression signatures for bacterial/viral discrimination
2022 · Nicholas Bodkin, Melissa Ross, et al. · Genome Medicine · 39
PDF
Effect of Thromboprophylaxis on Clinical Outcomes After COVID-19 Hospitalization
2023 · Tracy Y. Wang, Abdus S. Wahed, et al. · Annals of Internal Medicine · 36
PDF
Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19
2022 · ACTIV-3/TICO Study Group*, Christina Barkauskas, et al. · Annals of Internal Medicine · 31
PDF
Prospective Validation of a Rapid Host Gene Expression Test to Discriminate Bacterial From Viral Respiratory Infection
2022 · Emily R. Ko, Ricardo Henao, et al. · JAMA Network Open · 30
PDF
The host response as a tool for infectious disease diagnosis and management
2018 · Emily C. Lydon, Emily R. Ko, et al. · Expert Review of Molecular Diagnostics · 28
What was old is new again: using the host response to diagnose infectious disease
2015 · Emily R Ko, William E Yang, et al. · Expert Review of Molecular Diagnostics · 27
Efficacy and safety of azithromycin versus placebo to treat lower respiratory tract infections associated with low procalcitonin: a randomised, placebo-controlled, double-blind, non-inferiority trial
2022 · Ephraim L Tsalik, Nadine G Rouphael, et al. · The Lancet Infectious Diseases · 26
A conserved acidic patch in the Myb domain is required for activation of an endogenous target gene and for chromatin binding
2008 · Emily Ray Ko, Dennis Ko, et al. · Molecular Cancer · 26
PDF
A miRNA Host Response Signature Accurately Discriminates Acute Respiratory Infection Etiologies
2018 · Gregory D. Poore, Emily R. Ko, et al. · Frontiers in Microbiology · 21
PDF
Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial
2023 · Samuel M Brown, Christina E Barkauskas, et al. · The Lancet Respiratory Medicine · 19
PDF
Average Weighted Accuracy: Pragmatic Analysis for a Rapid Diagnostics in Categorizing Acute Lung Infections (RADICAL) Study
2019 · Ying Liu, Ephraim L Tsalik, et al. · Clinical Infectious Diseases · 19
PDF
Effect of P2Y12 Inhibitors on Organ Support–Free Survival in Critically Ill Patients Hospitalized for COVID-19
2023 · Jeffrey S. Berger, Matthew D. Neal, et al. · JAMA Network Open · 16
PDF
Screening tools for predicting mortality of adults with suspected sepsis: an international sepsis cohort validation study
2023 · Paul W Blair, Rittal Mehta, et al. · BMJ Open · 16
PDF
Works count: 66
Citation count: 3,325
H-index: 21
I10-index: 29
Year
Topic
Type